Navigation

🏠 Home 📰 Latest News 🌍 World 🇮🇳 India 💼 Business 💻 Technology ⚽ Sports 🎬 Entertainment 🏥 Health
Biggest News Aggregation in the World
📰 Per Protocol Analysis Set News

Per Protocol Analysis Set News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Per Protocol Analysis Set. Real-time updates on events, politics, business and more.

Precigen ActoBio Announces Additional Positive Interim Data from Phase 1b/2a Study of AG019 ActoBiotics™, A Novel Therapy Designed to Address the Underlying Cause of Type 1 Diabetes

October 1, 2021
/PRNewswire/ -- Precigen ActoBio, an innovative clinical-stage biotechnology company focused on a new class of microbe-based therapeutic agents and a...
United States Pieter Rottiers Katholieke Universiteit Leuven Chantal Mathieu Steven Harasym Precigen Actobio
Source: prnewswire.com

Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial

October 1, 2021
In a phase 2 randomized placebo-controlled trial, Neil Formica and coauthors investigate the immunogenicity and safety of different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine in younger and older adults in USA and Australia.
United Kingdom United States New Zealand South Africa Baylor College Of Medicine Mark Adams
Source: plos.org

Precigen ActoBio Announces Positive Topline Results from Phase 1b/2a Study of AG019 ActoBiotics™, A Novel Therapy Designed to Address the Underlying Cause of Type 1 Diabetes

June 10, 2021
/PRNewswire/ -- Precigen ActoBio, an innovative clinical-stage biotechnology company focused on a new class of microbe-based therapeutic agents and a...
Kevan Herold Pieter Rottiers Steven Harasym Precigen Actobio Federation Of Clinical Immunology Societies Yale University
Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science